BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22820649)

  • 1. FDG PET/CT is useful for the interim evaluation of response to therapy in patients affected by haematogenous spondylodiscitis.
    Nanni C; Boriani L; Salvadori C; Zamparini E; Rorato G; Ambrosini V; Gasbarrini A; Tumietto F; Cristini F; Scudeller L; Boriani S; Viale P; Fanti S
    Eur J Nucl Med Mol Imaging; 2012 Oct; 39(10):1538-44. PubMed ID: 22820649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective comparison of whole-body (18)F-FDG PET/CT and MRI of the spine in the diagnosis of haematogenous spondylodiscitis.
    Fuster D; Tomás X; Mayoral M; Soriano A; Manchón F; Cardenal C; Monegal A; Granados U; Garcia S; Pons F
    Eur J Nucl Med Mol Imaging; 2015 Feb; 42(2):264-71. PubMed ID: 25186431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of FDG PET/CT in patients treated with neoadjuvant chemotherapy for localized bone sarcomas.
    Palmerini E; Colangeli M; Nanni C; Fanti S; Marchesi E; Paioli A; Picci P; Cambioli S; Donati D; Cevolani L; De Paolis M; Gambarotti M; Ferrari S
    Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):215-223. PubMed ID: 27645694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of 18F-FDG-PET-CT for Assessment of Response to Neoadjuvant Chemotherapy in Children With Wilms Tumor.
    Qin Z; Tang Y; Wang H; Cai W; Fu H; Li J; Ma C
    J Pediatr Hematol Oncol; 2015 Jul; 37(5):396-401. PubMed ID: 25749587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of early response to concomitant chemoradiotherapy by interim 18F-FDG PET/CT imaging in patients with locally advanced oesophageal carcinomas.
    Cuenca X; Hennequin C; Hindié E; Rivera S; Vercellino L; Baruch-Hennequin V; Gornet JM; Cattan P; Chirica M; Quéro L
    Eur J Nucl Med Mol Imaging; 2013 Apr; 40(4):477-85. PubMed ID: 23371374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Clinical Role of Dual-Time-Point (18)F-FDG PET/CT in Differential Diagnosis of the Thyroid Incidentaloma.
    Lee S; Park T; Park S; Pahk K; Rhee S; Cho J; Jeong E; Kim S; Choe JG
    Nucl Med Mol Imaging; 2014 Jun; 48(2):121-9. PubMed ID: 24900152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorine-18 fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography scan contributes to the diagnosis and management of brucellar spondylodiskitis.
    Ioannou S; Chatziioannou S; Pneumaticos SG; Zormpala A; Sipsas NV
    BMC Infect Dis; 2013 Feb; 13():73. PubMed ID: 23388066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of chemotherapy response by PET-CT in osteosarcoma: correlation with histologic necrosis.
    Bajpai J; Kumar R; Sreenivas V; Sharma MC; Khan SA; Rastogi S; Malhotra A; Gamnagatti S; Kumar R; Safaya R; Bakhshi S
    J Pediatr Hematol Oncol; 2011 Oct; 33(7):e271-8. PubMed ID: 22193290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher fluorine-18 fluorodeoxyglucose positron emission tomography (FDG-PET) uptake in tuberculous compared to bacterial spondylodiscitis.
    Bassetti M; Merelli M; Di Gregorio F; Della Siega P; Screm M; Scarparo C; Righi E
    Skeletal Radiol; 2017 Jun; 46(6):777-783. PubMed ID: 28299432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of response to neoadjuvant chemotherapy in osteosarcoma using dual-phase (18)F-FDG PET/CT.
    Byun BH; Kim SH; Lim SM; Lim I; Kong CB; Song WS; Cho WH; Jeon DG; Lee SY; Koh JS; Chung SK
    Eur Radiol; 2015 Jul; 25(7):2015-24. PubMed ID: 25680716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18F-FDG-PET/CT better localizes active spinal infection than MRI for successful minimally invasive surgery.
    Nakahara M; Ito M; Hattori N; Magota K; Takahata M; Nagahama K; Sudo H; Kamishima T; Tamaki N; Iwasaki N
    Acta Radiol; 2015 Jul; 56(7):829-36. PubMed ID: 25080515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of (18)F-FDG PET/CT methods of analysis for predicting response to neoadjuvant chemoradiation therapy in patients with locally advanced low rectal cancer.
    Altini C; Niccoli Asabella A; De Luca R; Fanelli M; Caliandro C; Quartuccio N; Rubini D; Cistaro A; Montemurro S; Rubini G
    Abdom Imaging; 2015 Jun; 40(5):1190-202. PubMed ID: 25348731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuberculous lymphadenitis: FDG PET and CT findings in responsive and nonresponsive disease.
    Sathekge M; Maes A; D'Asseler Y; Vorster M; Gongxeka H; Van de Wiele C
    Eur J Nucl Med Mol Imaging; 2012 Jul; 39(7):1184-90. PubMed ID: 22526957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incremental value of FDG-PET/CT to monitor treatment response in infectious spondylodiscitis.
    Righi E; Carnelutti A; Muser D; Di Gregorio F; Cadeo B; Melchioretto G; Merelli M; Alavi A; Bassetti M
    Skeletal Radiol; 2020 Jun; 49(6):903-912. PubMed ID: 31900514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ¹⁸F-FDG PET SUVmax as an indicator of histopathologic response after neoadjuvant chemotherapy in extremity osteosarcoma.
    Kong CB; Byun BH; Lim I; Choi CW; Lim SM; Song WS; Cho WH; Jeon DG; Koh JS; Yoo JY; Lee SY
    Eur J Nucl Med Mol Imaging; 2013 May; 40(5):728-36. PubMed ID: 23361860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary clinical assessment of dynamic
    Shinya T; Otomi Y; Kubo M; Kinoshita M; Takechi K; Uyama N; Yamanaka M; Terazawa K; Toba H; Bando Y; Otsuka H; Harada M
    Ann Nucl Med; 2019 Jun; 33(6):414-423. PubMed ID: 30911883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases].
    Xu XX; Cheng J; Xu WG; Dai D; Song XY; Ma WC; Zhu L; Zhu X
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):364-8. PubMed ID: 22883458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The utility of 2-[
    Sebro R; Ashok SS
    Eur Radiol; 2021 Sep; 31(9):6780-6792. PubMed ID: 33686475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between HER2 expression and
    Ozen A; Tatar G
    Hell J Nucl Med; 2022; 25(1):5-10. PubMed ID: 35388798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual-time-point F-18 FDG PET/CT imaging for differentiating the lymph nodes between malignant lymphoma and benign lesions.
    Nakayama M; Okizaki A; Ishitoya S; Sakaguchi M; Sato J; Aburano T
    Ann Nucl Med; 2013 Feb; 27(2):163-9. PubMed ID: 23188388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.